Emerging EGFR-Mutated Subclones in a Patient With Metastatic ALK-Rearranged Lung Adenocarcinoma Treated With ALK-Targeted Therapy: A Case Report by Jackson Ka Chun Leung, M.B.B.S., Wang Chun Kwok, M.B.B.S., Arthur Chun Fung Leung, M.B.B.S., Po Tsui, FHKCPath, James Chung-Man Ho, MD, FRCP

Get full text

Feasibility of Aerobic Exercise and Tai-Chi Interventions in Advanced Lung Cancer Patients: A Randomized Controlled Trial by Denise Shuk Ting Cheung PhD, Naomi Takemura BN, Tai Chung Lam MBBS, James Chung Man Ho MD, Wen Deng PhD, Robert Smith PhD, Yinxia Yan PhD, Anne Wing Mui Lee MD, Chia Chin Lin PhD, FAAN

Get full text

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC by Qing Zhou, MD, PhD, Ross A. Soo, MBBS, PhD, Gee-Chen Chang, MD, PhD, Chao-Hua Chiu, MD, Hidetoshi Hayashi, MD, PhD, Sang-We Kim, MD, PhD, Shunsuke Teraoka, MD, Yasushi Goto, MD, PhD, Jianying Zhou, MD, Victor Ho-Fun Lee, MD, Dong-Wan Kim, MD, PhD, Baohui Han, MD, PhD, James Chung Man Ho, MD, FRCP, Chia-Chi Lin, MD, PhD, Shun Lu, MD, Anna Polli, BS, Anna Maria Calella, PhD, Jean-François Martini, PhD, Chew Hooi Wong, PhD, Tony Mok, MD, Hye Ryun Kim, MD, PhD, Yi-Long Wu, MD

Get full text